WT1-specific serum antibodies in patients with leukemia

Clinical Cancer Research

Volumn 7, Issue 11 SUPPL., 2001, Pages

  Gaiger, Alexander ^a,b   Carter, Lauren ^a   Greinix, Hildegard ^b   Carter, Darrick ^a   McNeill, Patricia D ^a   Houghton, Raymond L ^a   Cornellison, Charisa D ^a   Vedvick, Thomas S ^a   Skeiky, Yasir A W ^a   Cheever, Martin A ^a  

^a GLAXOSMITHKLINE   (United States)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COMPLEMENTARY DNA; DNA BINDING PROTEIN; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR; WT1 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BLOOD; CHRONIC MYELOID LEUKEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOLOGY; LEUKEMIA; METABOLISM; MORTALITY;

ADULT; ANTIBODIES; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LEUKEMIA; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; RECOMBINANT PROTEINS; TRANSCRIPTION FACTORS; WT1 PROTEINS;

EID: 0035287994     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ohminami, H., Yasukawa, M., and Fujita, S. HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide. Blood, 95: 286-293, 2000.
2. Gao, L., Bellantuono, I., Elsaesser, A., Marley, S. B., Gordon, M. Y., and Goodman, J. M. Selective elimination of leukemic CD34+ progenitor cells by cytotoxic T lymphocytes specific for WT1. Blood, 95: 2198-2203, 2000.
3. Gaiger, A., Reese, V., Disis, M. L., and Cheever, M. A. Immunity to WT1 in the animal model and in patients with acute myeloid leukemia. Blood, 96: 1480-1489, 2000.
4. Pritchard-Jones, K., Fleming, S., Davidson, D., Bickmore, W., Porteous, D., Gosden, C., Bard, J., Buckler, A., Pelletier, J., Housman, D., et al. The candidate Wilms' tumour gene is involved in genitourinary development. Nature (Lond.), 346: 194-199, 1990.
5. Mundlos, S., Pelletier, J., Darveau, A., Bachmann, M., Winterpacht, A., and Zabel, B. Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues. Development (Camb.), 119: 1329-1341, 1993.
6. Haber, D. A., Buckler, A. J., Glaser, T., Call, K. M., Pelletier, J., Sohn, R. L., Douglass, E. C., and Houseman, D. E. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilm's tumor. Cell, 61: 1257-1269, 1990.
7. Call, K. M., Glaser, T., Ito, C. Y., Buckler, A. J., Pelletier, J., Haber, D. A., Rose, E. A., Karl, A., Lewis, W. H., Jones, C., and Housman, D. E. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell, 60: 509-520, 1990.
8. Miwa, H., Beran, M., and Saunders, G. F. Expression of the Wilms' tumor gene (Wt1) in human leukemias. Leukemia (Baltimore), 6: 405-409, 1992.
9. Miyagi, T., Ahuja, H., Kubota, T., Kubonishi, I., Koeffler, H. P., and Miyoshi, I. Expression of the candidate Wilms' tumor gene. Wt-1, in human leukemia cells. Leukemia (Baltimore), 7; 970-977, 1993.
10. Inoue, K., Sugiyama, H., Ogawa, H., Nakagawa, M., Yamagami, T., Miwa, H., Kita, K., Hiraoka, A., Masaoka, T., Nasu, K., Kyo, T., Dohy, H., Nakauchi, H., Ishidate, T., Akiyama, T., and Kishimoto, T. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood, 84: 3071-3079, 1994.
11. Bergmann, L., Miething, C., Maurer, U., Brieger, J., Karakas, T., Weidmann, E., and Hoelzer, D. High levels of Wilms' tumor gene (HT1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood, 90: 1217-1225, 1997.
12. Menssen, H. D., Renkl, H. J., Rodeck, U., Kari, C., Schwartz, S., and Thiel, E. Detection by monoclonal antibodies of the Wilms' tumor (WT1) nuclear protein in patients with acute leukemia. Int. J. Cancer, 70: 518-523, 1997.
13. Schmid, D., Heinze, G., Linnerth, B., Tisljar, K., Kusec, R., Geissler, K., Sillaber, C., Laczika, K., Mitterbauer, M., Zoechbauer, S., Mannhalter, C., Haas, O. A., Lechner, K., Jaeger, U., and Gaiger, A. Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia. Leukemia (Baltimore), 11: 634-643, 1997.
14. Gaiger, A., Linnerth, B., Mann, G., Schmid, D., Heinze, G., Tisljar, K., Haas, O. A., Gadner, H., and Lion, T. Wilms' tumour gene (WT1) expression at diagnosis has no prognostic relevance in childhood acute lymphoblastic leukaemia treated by an intensive chemotherapy protocol. Eur. J. Haematol., 63: 86-93, 1999.
15. Patmasiriwat, P., Fraizer, G., Kantarjian, H., and Saunders, G. F. WT1 and GATAI expression in myelodysplastic syndrome and acute leukemia. Leukemia (Baltimore), 13: 891-900, 1999.
16. Algar, E. M., Khromykh, T., Smith, S. I., Blackburn, D. M., Bryson, G. J., and Smith, P. J. A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukemia cell lines. Oncogene, 12: 1005-1014, 1996.
17. Yamagami, T., Sugiyama, H., Inoue, K., Ogawa, H., Tatekawa, Y., Hirata, M., Kudoh, T., Akiyama, T., Murakami, A., Maekawa, T., and Kishimoto, T. Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis. Blood, 87: 2878-2884, 1996.
18. Svedberg, H., Chylicki, K., Baldetorp, B., Rauscher, F. J., III, and Gullberg, U. Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program. Oncogene, 16: 925-932, 1998.
19. Tsuboi, A., Oka, Y., Ogawa, H., Elisseeva, O. A., Tamaki, H., Oji, Y., Kim, E. H., Soma, T., Tatekawa, T., Kawakami, M., Kishimoto, T., and Sugiyama, H. Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF). Leuk. Res., 23: 499-505, 1999.
20. Baird, P. N., and Simmons, P. J. Expression of the Wilms' tumor gene (WT1) in normal hemopoiesis. Exp. Hematol., 25: 312-320, 1997.
21. Skeiky, Y. A., Lodes, M. J., Guderian, J. A., Mohamath, R., Bement, T., Alderson, M. R., and Reed, S. G. Cloning, expression, and immunological evaluation of two putative secreted serine protease antigens of Mycobacterium tuberculosis. Infect. Immun., 67: 3998-4007, 1999.
22. Hochuli, E. Genetically designed affinity chromatography using a novel metal chelate absorbent. Biologically Active Molecules, 2: 213-223, 1989.
23. Disis, M. L., and Cheever, M. A. Oncogenic proteins as tumor antigens. In: F. Alt and P. Marrack (eds.), Current Opinion in Immunology, Vol. 5, pp. 637-642. London: Current Biology, Ltd., 1996.
24. Haber, D. A., Sohn, R. L., Buckler, A. J., Pelletier, J., Call, K. M., and Housman, D. E. Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc. Natl. Acad. Sci. USA, 88: 9618-9622, 1991.
25. Rauscher, F. J., Ill, Morris, J. F., Tournay, O. E., Cook, D. M., and Curran, T. Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science (Washington DC), 250: 1259-1262, 1990.
26. Madden, S. L., Cook, D. M., Morris, J. F., Cashler, A., Sukhatme, V. P., and Rauscher, F. J., III. Transcriptional repression mediated by the WT1 Wilms tumor gene product. Science (Washington DC), 253: 1550-1553, 1991.